Just as patients with high blood pressure require medication, individuals experiencing weight regain after VSG may need medical interventions beyond lifestyle modifications
Tirzepatide hits both GLP-1 and GIP receptors simultaneously
For example, both molecules can stimulate dopamine release, a neurotransmitter well-known for being the "pleasure center" of the brain
I would not recommend microdosing GLP-1s for individuals with significant amounts of weight to lose or known metabolic dysregulation. The bottom line is that there are still questions regarding the effectiveness and safety of microdosing GLP-1 medications, and this type of regimen is not for everyone
Some people were already on their knees when their injection was cancelled because the last one they had was in December, how exactly are they supposed to function
View on NEJM Aronne LJ, Sattar N, Horn DB, et al